Last reviewed · How we verify
Ansadol (salicylanilide)
Ansadol (generic name: salicylanilide) is a salicylanilide drug. It is currently in unknown development.
Ansadol is thought to work by modulating a specific biological pathway, although the exact mechanism is not well understood.
Ansadol is a chemical compound classified as both a salicylamide and an anilide, being the amide of salicylic acid and aniline. It is composed of salicylic acid and aniline combined through an amide bond.
At a glance
| Generic name | salicylanilide |
|---|---|
| Drug class | salicylanilide |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine Ansadol as a key that fits into a lock in our cells. When it binds to its target, it can turn on or off certain cellular processes, which can help to treat a variety of diseases. However, the exact lock and key mechanism of Ansadol is still a mystery.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ansadol CI brief — competitive landscape report
- Ansadol updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Ansadol
What is Ansadol?
How does Ansadol work?
What is the generic name of Ansadol?
What drug class is Ansadol in?
What development phase is Ansadol in?
Related
- Drug class: All salicylanilide drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing